We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer Silences Testimony On Short-Term Prempro Use

Law360 (January 21, 2011, 7:38 PM EST) -- Plaintiffs in multidistrict litigation over Pfizer Inc.'s hormone replacement drug Prempro cannot present expert testimony that short-term use of the drug increases breast cancer risk, a judge has ruled on the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.